How does a painkiller harm the heart?

Nature

Volumn 441, Issue 7091, 2006, Pages 262-

  Wadman, Meredith ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; NAPROXEN; ROFECOXIB; ANALGESIC AGENT; LACTONE; PROSTACYCLIN; SULFONE; THROMBOXANE;

ARTHRITIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; DATA ANALYSIS; ENZYME INHIBITION; HEART INFARCTION; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG INDUSTRY; HEART DISEASE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANALGESICS; ANIMALS; DRUG INDUSTRY; EPOPROSTENOL; HEART DISEASES; HUMANS; LACTONES; MICE; RANDOMIZED CONTROLLED TRIALS; SULFONES; THROMBOXANES;

EID: 33745008147     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/441262a     Document Type: Note

References (4)

1. Lévesque, L. E., Brophy, J. M. & Zhang, B. Can. Med. Assoc. J. 174, doi:10.1503/cmaj.051679 (2006).
2. Merck APPROVe report (2006); www.merck.com/newsroom/pdf/ APPROVe_Study_Summary_Report.pdf
3. Bresalier, R. S. et al. N. Engl. J. Med. 352, 1092-1102 (2005).
4. Steffel, J. et al. Circulation 111, 1685-1689 (2005).